Pulse Biosciences, Inc. (PLSE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 925.34M |
| Enterprise Value | 852.13M |
| P/E Ratio | -23.59 |
| PEG Ratio | 2.22 |
| Price/Sales Ratio | 2,369.35 |
| Price/Book Ratio | 26.29 |
| Enterprise/Revenue | 2,287.91 |
| Enterprise/EBITDA | -23.19 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -99.29 |
| Operating Margin | -103.92 |
| Return On Assets | -0.91 |
| Return On Equity | -0.87 |
| Revenue | 350,000 |
| Revenue/Share | 0.01 |
| Gross Profit | -1.26M |
| EBITDA | -71.71M |
| Net Income | -72.78M |
| Diluted EPS | -1.08 |
| Total Cash | 68.32M |
| Total Cash/Share | 1.01 |
| Total Debt | 7.16M |
| Total Debt/Equity | 0.11 |
| Current Ratio | 7.26 |
| Book Value Per Share | 0.98 |
| 52-Week Change | 65.98 |
| 52-Week High | 28.53 |
| 52-Week Low | 12.56 |
| Moving Average 50 Days | 23.3 |
| Moving Average 200 Days | 18.62 |
| Average Volume | 308,238 |
| Shares Outstanding | 69.21M |
| % Held by Institutions | 11.53 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |